Baidu
map

PLoS One:双氢青蒿素诱导肝癌细胞凋亡

2012-07-09 Beyond 生物谷

肝癌患病率和死亡率是所有癌症中的前五位,科研界也一直关注于开发治疗肝癌的新策略。青蒿素(artemisinin)是我国科研人员率先从“黄花蒿”中分离提取得到的一种高效低毒抗疟药物。青蒿素内含有独特的过氧化物桥,可以与亚铁离子结合反应形成氧自由基,诱导细胞发生分子损伤和细胞死亡,或通过直接氧化作用损伤细胞的结构和功能,从而导致细胞死亡。 双氢青蒿素(dihydroartemisinin,DHA)是

肝癌患病率和死亡率是所有癌症中的前五位,科研界也一直关注于开发治疗肝癌的新策略。青蒿素(artemisinin)是我国科研人员率先从“黄花蒿”中分离提取得到的一种高效低毒抗疟药物。青蒿素内含有独特的过氧化物桥,可以与亚铁离子结合反应形成氧自由基,诱导细胞发生分子损伤和细胞死亡,或通过直接氧化作用损伤细胞的结构和功能,从而导致细胞死亡。

双氢青蒿素(dihydroartemisinin,DHA)是青蒿素药物在体内的主要代谢物,与青蒿素比较,DHA具有水溶性更好,抗疟效力更强的特点。近年来研究表明,双氢青蒿素(DHA)对肝癌具有抗肿瘤活性。

近日PLoS One杂志刊登的一项项研究中,科学家证明,组蛋白去乙酰酶抑制剂(HDACi)通过增加体外和体内肿瘤细胞的凋亡显著增强DHA的抗肿瘤作用。DHA诱导细胞凋亡归因于抑制ERK磷酸化,联用ERK磷酸化抑制剂PD98059能增加DHA诱导凋亡功效。

仅与DHA单用相比, DHA与HDACI综合治疗能降低线粒体膜电位,释放细胞色素c到细胞质中,增加了P53和Bak表达,减少Mcl-1和p-ERK表达,同时caspase3和PARP的活化也增加,这些效应一致诱导肿瘤细胞凋亡。

此外,研究发现HDACI预处理肿瘤细胞有利于DHA诱导细胞凋亡。HepG2细胞裸鼠模型中,腹腔注射DHA和SAHA能显著抑制肿瘤的生长。TUNEL和H&E染色结果表明联合治疗抑制细胞生长的原因是能诱导肿瘤细胞凋亡。免疫组化数据显示PARP活化,Ki-67、p-ERK和Mcl-1表达下降。

总之数据表明,HDACi和DHA的结合使用可能是一个对肝癌有抗肿瘤作用的非常有前途的治疗策略。

doi:10.1371/journal.pone.0039870
PMC:
PMID:

Histone Deacetylase Inhibitors Facilitate Dihydroartemisinin-Induced Apoptosis in Liver Cancer In Vitro and In Vivo

Chris Zhiyi Zhang, Yinghua Pan, Yun Cao, Paul B. S. Lai, Lili Liu, George Gong Chen*, Jingping Yun*

Liver cancer ranks in prevalence and mortality among top five cancers worldwide. Accumulating interests have been focused in developing new strategies for liver cancer treatment. We have previously showed that dihydroartemisinin (DHA) exhibited antitumor activity towards liver cancer. In this study, we demonstrated that histone deacetylase inhibitors (HDACi) significantly augmented the antineoplastic effect of DHA via increasing apoptosis in vitro and in vivo. Inhibition of ERK phosphorylation contributed to DHA-induced apoptosis, due to the fact that inhibitor of ERK phosphorylation (PD98059) increased DHA-induced apoptosis. Compared with DHA alone, the combined treatment with DHA and HDACi reduced mitochondria membrane potential, released cytochrome c into cytoplasm, increased p53 and Bak, decreased Mcl-1 and p-ERK, activated caspase 3 and PARP, and induced apoptotic cells. Furthermore, we showed that HDACi pretreatment facilitated DHA-induced apoptosis. In Hep G2-xenograft carrying nude mice, the intraperitoneal injection of DHA and SAHA resulted in significant inhibition of xenograft tumors. Results of TUNEL and H&E staining showed more apoptosis induced by combined treatment. Immunohistochemistry data revealed the activation of PARP, and the decrease of Ki-67, p-ERK and Mcl-1. Taken together, our data suggest that the combination of HDACi and DHA offers an antitumor effect on liver cancer, and this combination treatment should be considered as a promising strategy for chemotherapy.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1976352, encodeId=13aa19e635201, content=<a href='/topic/show?id=0ae08128e66' target=_blank style='color:#2F92EE;'>#肝癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81287, encryptionId=0ae08128e66, topicName=肝癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Wed Aug 08 14:55:00 CST 2012, time=2012-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789451, encodeId=b3c81e8945133, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Feb 06 05:55:00 CST 2013, time=2013-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251897, encodeId=8cc0125189e60, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Wed Jul 11 06:55:00 CST 2012, time=2012-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340235, encodeId=0d1f1340235dd, content=<a href='/topic/show?id=bd5ce780493' target=_blank style='color:#2F92EE;'>#细胞凋亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77804, encryptionId=bd5ce780493, topicName=细胞凋亡)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/EFCEF19303EB52B3F41B30C45995AF2C/100, createdBy=8e712500159, createdName=ms8538335253054589, createdTime=Wed Jul 11 06:55:00 CST 2012, time=2012-07-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1976352, encodeId=13aa19e635201, content=<a href='/topic/show?id=0ae08128e66' target=_blank style='color:#2F92EE;'>#肝癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81287, encryptionId=0ae08128e66, topicName=肝癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Wed Aug 08 14:55:00 CST 2012, time=2012-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789451, encodeId=b3c81e8945133, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Feb 06 05:55:00 CST 2013, time=2013-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251897, encodeId=8cc0125189e60, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Wed Jul 11 06:55:00 CST 2012, time=2012-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340235, encodeId=0d1f1340235dd, content=<a href='/topic/show?id=bd5ce780493' target=_blank style='color:#2F92EE;'>#细胞凋亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77804, encryptionId=bd5ce780493, topicName=细胞凋亡)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/EFCEF19303EB52B3F41B30C45995AF2C/100, createdBy=8e712500159, createdName=ms8538335253054589, createdTime=Wed Jul 11 06:55:00 CST 2012, time=2012-07-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1976352, encodeId=13aa19e635201, content=<a href='/topic/show?id=0ae08128e66' target=_blank style='color:#2F92EE;'>#肝癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81287, encryptionId=0ae08128e66, topicName=肝癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Wed Aug 08 14:55:00 CST 2012, time=2012-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789451, encodeId=b3c81e8945133, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Feb 06 05:55:00 CST 2013, time=2013-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251897, encodeId=8cc0125189e60, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Wed Jul 11 06:55:00 CST 2012, time=2012-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340235, encodeId=0d1f1340235dd, content=<a href='/topic/show?id=bd5ce780493' target=_blank style='color:#2F92EE;'>#细胞凋亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77804, encryptionId=bd5ce780493, topicName=细胞凋亡)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/EFCEF19303EB52B3F41B30C45995AF2C/100, createdBy=8e712500159, createdName=ms8538335253054589, createdTime=Wed Jul 11 06:55:00 CST 2012, time=2012-07-11, status=1, ipAttribution=)]
    2012-07-11 yxch36
  4. [GetPortalCommentsPageByObjectIdResponse(id=1976352, encodeId=13aa19e635201, content=<a href='/topic/show?id=0ae08128e66' target=_blank style='color:#2F92EE;'>#肝癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81287, encryptionId=0ae08128e66, topicName=肝癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Wed Aug 08 14:55:00 CST 2012, time=2012-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789451, encodeId=b3c81e8945133, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Feb 06 05:55:00 CST 2013, time=2013-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251897, encodeId=8cc0125189e60, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Wed Jul 11 06:55:00 CST 2012, time=2012-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340235, encodeId=0d1f1340235dd, content=<a href='/topic/show?id=bd5ce780493' target=_blank style='color:#2F92EE;'>#细胞凋亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77804, encryptionId=bd5ce780493, topicName=细胞凋亡)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/EFCEF19303EB52B3F41B30C45995AF2C/100, createdBy=8e712500159, createdName=ms8538335253054589, createdTime=Wed Jul 11 06:55:00 CST 2012, time=2012-07-11, status=1, ipAttribution=)]

相关资讯

Blood:PTPN22激活AKT促进白血病细胞生存

磷酸酶PTPN22多态性变异已与多种自身免疫性疾病风险增加有关。近日,一项刊登在Blood杂志上的研究表明,PTPN22在慢性淋巴细胞白血病(CLL)中也过度表达。 慢性淋巴细胞白血病属慢性淋巴细胞恶性克隆性疾病。多起源于B细胞的恶性转化,淋巴细胞分化受阻于未成熟阶段,易伴发自身免疫病和低丙球蛋白血症。 研究证实,过度表达的PTPN22通过阻断B细胞受体(BCR)负调控细胞生存的信号通路,显著

J Med Genet:脑胶质瘤遗传变异

近日,Moffitt癌症中心发表研究证实脑胶质瘤疾病中存在罕见的遗传基因变异。 Moffitt癌症中心研究人员证实一种罕见的遗传变异与脑胶质瘤风险有关,脑胶质瘤是脑肿瘤的最常见和最致命的类型之一。研究发现一个罕见的遗传性变异和胶质瘤患者生存率的改善有关联。 这项研究首次证实脑胶质瘤的中一种罕见的易感性变异,将发表在最近一期??的Journal of Medical Genetics杂志上。

Blood:科学家发现白血病致病蛋白

近日,辛辛那提大学(UC)Hoxworth血液中心研究人员发现治疗白血病的新靶基因。这一研究结果将于7月26日刊登在美国血液学会Blood杂志上。 这项研究由在加州大学医学部儿科副教授和Hoxworth血液中心研究部主任Jose Cancelas博士领导,研究团队在动物模型中抑制Vav3蛋白,从而控制细胞信号转导,动物发展患有 BCR-ABL淋巴白血病被延迟。 尽管治疗白血病的治疗手段

PNAS:唐功利等抗肿瘤天然产物生物合成研究获进展

对结构独特、活性显著的天然产物进行生物合成研究是从基因簇、生物合成途径及酶催化反应角度理解自然界“全合成”的生物-化学过程。中国科学院上海有机化学研究所生命有机化学国家重点实验室唐功利课题组多年来致力于复杂抗肿瘤天然产物的生物合成研究,经过几年的努力,该课题组最近在两个课题上均取得突破。 抗生素谷田霉素(Yatakemycin,YTM)可以抑制致病真菌,且对肿瘤细胞表现出极强的毒性(比抗肿瘤药物

Cancer Res:英研究发现与口腔癌相关蛋白质

近日,英国研究人员发现了一种在口腔癌中起关键作用的蛋白质,以它为靶点进行治疗可以延长患癌实验鼠的生命。这一发现有望为人类带来口腔癌新疗法。 英国癌症研究会等机构的研究人员在美国新一期《癌症研究》(Cancer Research)杂志上报告说,他们发现名为FRMD4A的蛋白质在口腔癌中起着关键作用。这种蛋白质会促进癌细胞生长,机体中这种蛋白质的含量越高,癌症就越容易扩散,或是越容易在治疗后复发。

PLoS ONE:阻断FGFR抑制肿瘤转移

成纤维细胞生长因子受体(FGFR)对肿瘤的生长和癌症病人的生存起着至关重要的作用。相比于其他受体酪氨酸激酶,科学家也一直将成纤维细胞生长因子(成纤维细胞生长因子)作为一种治疗癌症的靶标来开展研究。 近日,研究发现FGFR信号抑制后对原位乳腺66c14癌模型肿瘤生长、转移和淋巴血管形成的影响。体外研究表明FGFR抑制后,66c14细胞增殖比对照组慢。小鼠植入FGFR表达抑制的肿瘤细胞后,66c14

Baidu
map
Baidu
map
Baidu
map